Company Data
Moleculin Biotech Inc.
Ticker
MBRX
Current Price
$0.2804 -24.24%
Market Cap
$5.7M
Price Target
Refer to Report
Volume
1.2M
52wk Range
$0.1614 - $15.75
Overview
Moleculin Biotech Inc is a clinical-stage pharmaceutical company. The firm focus on the development of oncology drug candidates. The drug technologies used by the company are anthracycline, a portfolio of STAT3 inhibitors, and collection of inhibitors of glycolysis.